Diagnosis and Management of Methemoglobinemia

Clinical Presentation and Diagnostic Approach

Methemoglobinemia is diagnosed by measuring methemoglobin levels using co-oximetry on arterial blood gas analysis, which is the gold standard diagnostic test, as recommended by the American Society of Hematology 1, 2
The American Academy of Pediatrics and the American Society of Hematology suggest that cyanosis that is unresponsive to oxygen therapy, typically appearing when methemoglobin levels exceed 1.5%, is a key diagnostic clue 1, 2
The presence of chocolate-brown colored arterial blood when drawn, which remains dark despite exposure to air, is a diagnostic feature of methemoglobinemia, according to the American Society of Hematology 1
Discordance between pulse oximetry (SpO2) and arterial blood gas oxygen saturation (SaO2) is a significant finding, where pulse oximetry reads falsely low while calculated oxygen saturation on ABG appears normal, as noted by the American Thoracic Society 3

The American Society of Hematology recommends that methemoglobin levels between 10-30% are associated with cyanosis, dark brown blood, and patients are generally asymptomatic or present with headaches, tachycardia, and mild dyspnea 1, 2
Methemoglobin levels between 30-50% are associated with clinically significant tissue hypoxia, according to the American College of Emergency Physicians 3
Levels above 50% are associated with severe complications, including dysrhythmias, seizures, altered mental status, and coma, as stated by the American Heart Association 3
Methemoglobin levels above 70% are considered potentially lethal, according to the American Society of Hematology 1, 4, 5

Co-oximetry is the gold standard diagnostic test and must be performed to definitively diagnose methemoglobinemia, as recommended by the American Society of Hematology 1, 2
The American Academy of Pediatrics suggests that molecular testing with DNA analysis is considered the gold standard for diagnosing hereditary methemoglobinemia, with 90.9% expert consensus 1, 2, 4, 5
Next-generation sequencing (NGS) panels that include causative genes (CYB5R3 for enzyme deficiency, globin genes for hemoglobin M variants) are useful in diagnosing hereditary methemoglobinemia, according to the American Society of Human Genetics 1, 2, 4

The American College of Emergency Physicians recommends that treatment should not be delayed while establishing the hereditary versus acquired distinction, as this differentiation is not required for acute management 1, 2, 4, 5
Pulse oximetry readings are falsely reassuring and should never be used to rule out methemoglobinemia, as stated by the American Thoracic Society 3
Infants are at substantially higher risk due to lower CYB5R enzyme activity and higher fetal hemoglobin levels, requiring heightened clinical suspicion, according to the American Academy of Pediatrics 1, 4, 5, 3